Wei-Li Xia

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Henan Cancer Hospital(Current)

First Affiliated Hospital of Zhengzhou University

Henan Provincial People's Hospital

Sun Yat-sen University

Sun Yat-sen University Cancer Center

Wei-Li Xia is an author at Henan Cancer Hospital specializing in propensity score adjustment, prognostic factors analysis, and hepatocellular carcinoma pharmacotherapy.

Publications per year

2022–2024

Publications

Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study

Wei-Li Xia, Xiaohui Zhao, Yuan Guo et al. · Frontiers in Oncology · 2022 · 25 citations · Full text

Medicine, Oncology, Pharmacology +12

Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Wei-Li Xia, Xiao-Hui Zhao, Yuan Guo et al. · Clinical and Translational Gastroenterology · 2023 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas

Xiao-Hui Zhao, Hang Yuan, Wei-Li Xia et al. · Frontiers in Oncology · 2022 · 11 citations · Full text

Medicine, Oncology, Surgery +17

Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma

Yuan Guo, Ru-Chun Li, Wei-Li Xia et al. · World Journal of Gastrointestinal Oncology · 2024 · 10 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4